| Financial Year |
March 31 2023 |
| Monetary Funds |
1,966,360,047.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
320,406,593.42 |
| Advances to Suppliers |
49,578,516.57 |
| Other Receivables |
15,209,567.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
390,676.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,499,935.59 |
| Total Current Assets |
2,431,445,336.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
246,717,520.97 |
| Investment Properties |
-- |
| Fixed Assetes |
20,729,034.20 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
154,042,901.95 |
| R&D expenses |
-- |
| Goodwill |
17,543,621.95 |
| Long-Term Deferred and Prepaid Expenses |
1,428,264.75 |
| Deferred Income Tax Assets |
21,887,708.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
881,400,855.12 |
| Total Assets |
3,312,846,191.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
328,918,794.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,558,964.74 |
| Taxes Payable |
20,690,405.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,074,266.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
596,770.54 |
| Other Current Liabilities |
11,828,226.54 |
| Sub-Total of Current Liabilities |
653,784,879.14 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
49,917,532.11 |
| Sub-Total of Non-Current Liabilities |
54,304,468.19 |
| Total Liabilities |
708,089,347.33 |
| Paid-In Capital(Or Share Stock) |
438,896,835.00 |
| Capital Surplus |
1,339,447,561.11 |
| Surplus Reserve |
81,353,399.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
733,776,728.96 |
| Minority Stockholder's Interest |
20,772,273.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,583,984,571.10 |
| Owner's Equity（Stockholder's Equity） |
2,604,756,844.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,312,846,191.47 |
